TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
Pfizer Anti-Infectives AB
Closing information (x1000 EUR)
Closing information | 2022/11 | 2021/11 | 2020/11 |
Turnover |
123,850
|
32,288
|
150,459 |
Financial expenses |
43
|
124
|
0 |
Earnings before taxes |
37,997
|
-55,413
|
120,307 |
EBITDA |
43,458
|
-49,507 | |
Total assets |
144,661
|
111,634
|
167,788 |
Current assets |
10,283
|
21,266
|
100 |
Current liabilities |
57,263
|
50,547
|
61,887 |
Equity capital |
87,398
|
61,087
|
105,901 |
- share capital |
5
![]() |
5
![]() |
5 |
Employees (average) |
0
![]() |
0
![]() |
0 |
Financial ratios
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Solvency |
60.4%
|
54.7%
|
63.1% |
Turnover per employee | |||
Profit as a percentage of turnover |
30.7%
|
-171.6%
|
80.0% |
Return on assets (ROA) |
26.3%
|
-49.5%
|
71.7% |
Current ratio |
18.0%
|
42.1%
|
0.2% |
Return on equity (ROE) |
43.5%
|
-90.7%
|
113.6% |
Change turnover |
93,601
|
-117,014
|
150,459 |
Change turnover % |
309%
|
-78% | |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2022/11 | 2021/11 | 2020/11 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.